Clinical Trial: A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hidradenitis Suppurativa (HS)
Study Type: INTERVENTIONAL
Official Title: Lunsayil LTE: An Extension Trial Assessing Long-term Spesolimab Treatment in Patients With Hidradenitis Suppurativa (HS)
Brief Summary:
This study is open to people with hidradenitis suppurativa (HS) who have completed another study with spesolimab (study 1368-0098 (NCT05819398) or study 1368-0100).The purpose of this study is to find out how well people tolerate spesolimab and whether it helps people with HS in the long-term.For about 1.5 years, participants get spesolimab injections under the skin every 2 weeks.Participants are in the study for about 2 years.During this time, participants have 41 visits.24 visits are done at the study site.17…
Read more